The foundation of modern medicine lies in the precise manipulation of molecules, and at the heart of this process are critical chemical building blocks. Ethyl (1S)-1-Phenyl-3,4-Dihydroisoquinoline-2-Carboxylate (CAS: 180468-42-2) exemplifies such a vital component, playing an indispensable role in the pharmaceutical sector, particularly in the synthesis of Solifenacin. Its chemical structure and properties are carefully defined to meet the rigorous demands of drug manufacturing.
This compound, often referred to by synonyms like (1S)-ethyl 1-phenyl-1,2,3,4-tetrahydro-2-isoquinoline carboxylate, possesses a molecular formula of C18H19NO2 and a molecular weight of approximately 281.35. Its physical appearance is described as a colorless to pale yellow sticky oil, with a purity typically exceeding 98%. These characteristics are crucial for its function as an intermediate. The synthesis of such compounds often involves enantioselective processes to ensure the correct spatial arrangement of atoms, which is vital for biological activity in the final drug product. The ability to produce this intermediate with high chiral purity is a testament to the sophisticated chemical synthesis capabilities available today.
The primary application of Ethyl (1S)-1-Phenyl-3,4-Dihydroisoquinoline-2-Carboxylate is as an intermediate for Solifenacin, a muscarinic M3 receptor antagonist used to treat overactive bladder. This means that the reliable supply and consistent quality of this precursor directly impact the availability of this important medication. Pharmaceutical research and development teams rely heavily on such intermediates to explore new drug candidates and optimize existing synthesis routes. The availability of high-quality building blocks accelerates the pace of innovation in drug discovery.
As the global demand for effective treatments for conditions like OAB continues to grow, the importance of a stable and high-quality supply chain for intermediates like this one becomes even more pronounced. Manufacturers specializing in fine chemicals and pharmaceutical intermediates play a crucial role in meeting this demand. Their expertise in organic synthesis, process optimization, and quality assurance ensures that these essential chemical building blocks are available when and where they are needed, underpinning the development and production of life-improving medicines.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.